Larry Ellberger, Director at Celldex Therapeutics, Inc. (CLDX), bought 5,000 shares at $15.94 ($80K) on 2015-08-18, disclosed to the SEC on 2015-08-19.
Open-market purchase of $80k CLDX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.93 | 300 | $5K | 6.0% |
| 2 | $15.94 | 2,200 | $35K | 44.0% |
| 3 | $15.96 | 2,500 | $40K | 50.0% |
| Total | $15.95 avg | 5,000 | $80K | 100% |
| Filing → |
| CLDX | BUY | 2015-08-14 | $83K | — | Filing → |
| CLDX | SELL | 2013-12-10 | $434K | — | Filing → |
| CLDX | BUY | 2009-11-30 | $45K | — | Filing → |